• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝癌的间质反应及术后复发机制]

[The interstitial response and postoperation recurrent mechanism in liver cancer].

作者信息

Dai Y, Chen H, Wang N

机构信息

Department of Pathology, Secondary Military Medical University, Shanghai.

出版信息

Zhonghua Yi Xue Za Zhi. 1995 Nov;75(11):666-9, 709.

PMID:8697086
Abstract

Immunoactive cell group markers and glycoproteins of extracellular matrix and basement membrane (fibronectin, laminin, type IV collage) in 156 human hepatocellular carcinomas and their surrounding tissues were localized with immunoperoxidase technique. T lymphocytes were the major immunoactive cells in the regions of local invasion in liver cancer. The distributing patterns of the glycoproteins were similar to the results of previous reports, mainly localized in the surrounding cancer cells, interstitium and vessel walls or sinusoids in tumor, and tumor capsule. The patients, whose hepatocarcinomas showed stronger cell immunoactivity (T and help T cells were in the majority) and higher expression of glycoproteins of extracellular matrix and basement membrane had a longer tumor-free survival (63.2 to 12.8 months) and lower recurrences (P < 0.01). Of the 156 patients 92.9%, 82.6%, 65.4%, 44.2% and 30.8% and 1, 2, 3, 4 and 5 postoperative tumor-free years respectively with a total currence rate of 53.2% (83 patients). In the 83 recurrences, 65 were intrahepatic subclinical, which were promptly reresected 78.3%, recurrence related factors included tumor number and size, capsule infiltration, and portal veins involvement. Being different from those with single node, capsulated hepatocellular carcinomas and multiple/daughter ones had invisible tumor cells disseminated to the remnant liver. Those without capsule infiltration had a low recurrence rate, which agrees to the hypothesis that capsules can bar the dissemination of tumor cells. Additional results show that postoperative tumor recurrence is mainly pertinent to histopathological characteristics of the primary focus. According to the phenomenon that nearly 63.1% of recurrent liver carcinomas are located at the ipsilateral segment of the primary ones, we emphasize that the occurrence and recurrence of liver carcinoma are mainly unicentral.

摘要

采用免疫过氧化物酶技术对156例人肝细胞癌及其周围组织中的免疫活性细胞群标志物以及细胞外基质和基底膜的糖蛋白(纤连蛋白、层粘连蛋白、IV型胶原)进行定位。T淋巴细胞是肝癌局部浸润区域的主要免疫活性细胞。糖蛋白的分布模式与先前报道的结果相似,主要定位于肿瘤周围的癌细胞、间质、肿瘤内的血管壁或血窦以及肿瘤包膜。肝细胞癌细胞免疫活性较强(以T细胞和辅助性T细胞为主)且细胞外基质和基底膜糖蛋白表达较高的患者,无瘤生存期较长(63.2至12.8个月)且复发率较低(P<0.01)。156例患者术后分别有92.9%、82.6%、65.4%、44.2%和30.8%的患者无瘤生存1、2、3、4和5年,总复发率为53.2%(83例)。在83例复发患者中,65例为肝内亚临床复发,其中78.

相似文献

1
[The interstitial response and postoperation recurrent mechanism in liver cancer].[肝癌的间质反应及术后复发机制]
Zhonghua Yi Xue Za Zhi. 1995 Nov;75(11):666-9, 709.
2
Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.细胞外基质重塑增加与人类肝细胞癌的肿瘤进展相关。
Hepatology. 2001 Jul;34(1):82-8. doi: 10.1053/jhep.2001.25758.
3
Collagen type III and type IV detection in and around human hepatocellular carcinoma.
Gen Diagn Pathol. 1997 Feb;142(3-4):155-63.
4
Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.肝细胞癌肝移植的生存结果,比较丙型肝炎与其他肝硬化病因的影响。
Liver Transpl. 2007 Jun;13(6):807-13. doi: 10.1002/lt.21054.
5
Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.硬化型肝细胞癌的细胞和基质特征:与肝细胞癌及肝内胆管癌的比较
Pathol Int. 2005 Nov;55(11):724-31. doi: 10.1111/j.1440-1827.2005.01891.x.
6
[Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma].肿瘤部位树突状细胞与记忆性T淋巴细胞的关系及肝细胞癌的预后
Zhonghua Yi Xue Za Zhi. 2005 Mar 16;85(10):671-5.
7
Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.伴有淋巴细胞浸润的肝细胞癌的临床病理研究
Hepatology. 1998 Feb;27(2):407-14. doi: 10.1002/hep.510270214.
8
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.肝细胞癌肝切除术后复发:危险因素、治疗及预后
Surgery. 2007 Mar;141(3):330-9. doi: 10.1016/j.surg.2006.06.028. Epub 2006 Nov 1.
9
Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?肝细胞癌:在丙型肝炎发病率高的中心,它能否被视为肝移植存在争议的指征?
Liver Transpl. 2002 Nov;8(11):1020-7. doi: 10.1053/jlts.2002.35664.
10
Liver transplant for hepatocellular carcinoma: experience in a Saudi population.沙特人群中肝细胞癌的肝移植经验
Exp Clin Transplant. 2008 Mar;6(1):14-24.